Cargando…
Apela/Elabela/Toddler: New perspectives in molecular mechanism of heart failure
Background. Despite significant therapeutic advances, heart failure (HF) remains unacceptably high in morbidity and mortality. Additionally, its high-care and costs make HF a deadly and costly disease. First reported independently by two group of researchers, Apela/Elabela/Toddler (ELA) is the secon...
Autores principales: | Sunjaya, Anthony P., Sunjaya, Angela F., Ferdinal, Frans |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Magdi Yacoub Heart Foundation
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865182/ https://www.ncbi.nlm.nih.gov/pubmed/31799290 http://dx.doi.org/10.21542/gcsp.2019.15 |
Ejemplares similares
-
ELABELA/APELA Levels Are Not Decreased in the Maternal Circulation or Placenta among Women with Preeclampsia
por: Pritchard, Natasha, et al.
Publicado: (2018) -
Combating Donor Organ Shortage: Organ Care System Prolonging Organ Storage Time and Improving the Outcome of Heart Transplantations
por: Sunjaya, Angela Felicia, et al.
Publicado: (2019) -
Apelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system
por: Yang, Peiran, et al.
Publicado: (2015) -
Pooled Testing for Expanding COVID-19 Mass Surveillance
por: Sunjaya, Angela Felicia, et al.
Publicado: (2020) -
Evaluation of Serum Biomarkers and Other Diagnostic Modalities for Early Diagnosis of Preeclampsia
por: Sunjaya, Angela Felicia, et al.
Publicado: (2019)